This company has been marked as potentially delisted and may not be actively trading. Idera Pharmaceuticals (IDRA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IDRA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Energy Recovery Wins “Breakthrough Innovation Award†at IDRA World CongressDecember 16, 2024 | businesswire.comEkso Bionics (NASDAQ: EKSO)April 11, 2024 | fool.comKiniksa PharmaceuticalsNovember 15, 2023 | forbes.comNabriva Therapeutics AG (NBRVF)August 9, 2023 | investing.comMarginaliaApril 26, 2023 | npr.orgNA mysterious rift propels the story in ‘Take What You Need’March 17, 2023 | washingtonpost.comIdera Pharmaceuticals, Inc.: Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookJanuary 18, 2023 | finanznachrichten.deIdera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookJanuary 17, 2023 | finance.yahoo.comWhy Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionJanuary 10, 2023 | msn.comIdera (IDRA) Stock Soars on GlaxoSmithKline PartnershipJanuary 4, 2023 | thestreet.comIdera Pharmaceuticals, Inc.: Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 18, 2022 | finanznachrichten.deIdera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 14, 2022 | finance.yahoo.comIdera Pharma Acquires Rare Disease Player, Names New CEOSeptember 29, 2022 | finance.yahoo.comIdera Pharma Shares Rise Nearly 18% After Aceragen AcquisitionSeptember 28, 2022 | marketwatch.comIdera Pharmaceuticals Acquires AceragenSeptember 28, 2022 | finance.yahoo.comIdera Pharmaceuticals Stock (NASDAQ:IDRA), DividendsSeptember 27, 2022 | benzinga.comIdera Pharmaceuticals Reports Second Quarter 2022 Financial ResultsAugust 9, 2022 | finance.yahoo.comIdera halts melanoma trial for cancer candidate after early positive resultsMay 17, 2022 | seekingalpha.comWhy Are Idera Pharmaceuticals Shares Soaring TodayMay 17, 2022 | finance.yahoo.comIdera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMCMay 17, 2022 | finance.yahoo.comIdera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateMay 5, 2022 | finance.yahoo.comIdera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateMarch 31, 2022 | finance.yahoo.comIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Sees Large Increase in Short InterestJanuary 3, 2022 | marketbeat.comIdera Shares Fall After Early Tilsotolimod Data, Seeks Collaborating Partners For TLR9 AgonistDecember 15, 2021 | msn.comIdera Pharmaceuticals Announces Tilsotolimod UpdatesDecember 14, 2021 | finance.yahoo.com5 Penny Stocks To Buy According To Analysts & Targets Up To 341%December 8, 2021 | chron.comIdera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNovember 8, 2021 | finance.yahoo.comIdera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateAugust 9, 2021 | finance.yahoo.com Get Idera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IDRA Media Mentions By Week IDRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDRA News Sentiment▼0.000.92▲Average Medical News Sentiment IDRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDRA Articles This Week▼00▲IDRA Articles Average Week Get the Latest News and Ratings for IDRA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Idera Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Prime Medicine News Today Protalix BioTherapeutics News Today Inhibikase Therapeutics News Today Invizyne Technologies News Today CEL-SCI News Today ZIVO Bioscience News Today Cortexyme News Today AlloVir News Today AIM ImmunoTech News Today NKGen Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDRA) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Idera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Idera Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDRA Stock Alerts